SANOFI US SERVICES INC. for SANOFI US SERVICES INC
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report | Oct 17, 2008 | $1,240,000 | Replaced |
| 3rd Quarter - Amendment (this page) | Dec 18, 2008 | $1,270,000 | Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
provisions related to the R&D tax credit in S2209 "Research Credit Improvement Act of 2007"; HR1424 "Emergency Economic Stabilization Act of 2009"; and S41 "Research Competitiveness Act of 2007"
Foreign entity interest: To the degree that such public policies, either laws or regulations, impact sanofi-aventis U.S. Inc., so too sanofi-aventis SA, the foreign parent company identified on Form LD-1, will likewise be impacted.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN TAYLOR | — |
Medicare/Medicaid MMM
Issues related to the Medicaid program
Foreign entity interest: To the degree that such public policies, either laws or regulations, impact sanofi-aventis U.S. Inc., so too sanofi-aventis SA, the foreign parent company identified on Form LD-1, will likewise be impacted.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY CLARK | — |
Trade (domestic/foreign) TRD
Issues related to the issuance of compulsory licenses of innovative pharmaceuticals
Foreign entity interest: To the degree that such public policies, either laws or regulations, impact sanofi-aventis U.S. Inc., so too sanofi-aventis SA, the foreign parent company identified on Form LD-1, will likewise be impacted.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN TAYLOR | — |
Health Issues HCR
Cancer awareness, including women's cancer program; issues related to Deep Vein Thrombosis (DVT) awareness and quality of care; issues related to diabetes care in the federal healthcare programs; and issues related to men's health
Foreign entity interest: To the degree that such public policies, either laws or regulations, impact sanofi-aventis U.S. Inc., so too sanofi-aventis SA, the foreign parent company identified on Form LD-1, will likewise be impacted.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY CLARK | — |
| MARK COIN | — |
| RICHARD M HODGE | — |
| SAIRA SULTAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.